Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-20-011716
Filing Date
2020-06-15
Accepted
2020-06-15 21:24:14
Documents
2
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp130268_3-norden.html 3  
1 FORM 3 dp130268_3-norden.xml 3 3808
2 EXHIBIT 24.1 dp130268_ex2401.htm EX-24.1 6235
  Complete submission text file 0000950103-20-011716.txt   11381
Mailing Address 16640 CHESTERFIELD GROVE DRIVE SUITE 200 CHESTERFIELD MO 63005
Business Address
Norden Gregory (Reporting) CIK: 0001405104 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39329 | Film No.: 20964820

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations